Dyne Therapeutics, Inc. (DYN)
25.99
-0.11
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
26.00
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Total Assets (Quarterly) : 994.01M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 994.01M |
| March 31, 2026 | 1.080B |
| December 31, 2025 | 1.187B |
| September 30, 2025 | 867.06M |
| June 30, 2025 | 728.99M |
| March 31, 2025 | 721.07M |
| December 31, 2024 | 691.23M |
| September 30, 2024 | 768.84M |
| June 30, 2024 | 825.88M |
| March 31, 2024 | 522.28M |
| December 31, 2023 | 165.08M |
| September 30, 2023 | 205.24M |
| June 30, 2023 | 251.42M |
| March 31, 2023 | 288.64M |
| Date | Value |
|---|---|
| December 31, 2022 | 306.32M |
| September 30, 2022 | 299.68M |
| June 30, 2022 | 340.03M |
| March 31, 2022 | 387.76M |
| December 31, 2021 | 425.66M |
| September 30, 2021 | 466.88M |
| June 30, 2021 | 467.15M |
| March 31, 2021 | 491.71M |
| December 31, 2020 | 353.33M |
| September 30, 2020 | 381.47M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 16.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vor Biopharma, Inc. | 481.05M |
| Neurocrine Biosciences, Inc. | 5.359B |
| Recursion Pharmaceuticals, Inc. | 1.213B |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 291.86M |
| Shareholders Equity (Quarterly) | 702.15M |
| Debt to Equity Ratio | 0.3323 |
| Current Ratio | 12.02 |
| Net Debt Paydown Yield | -1.14% |